New guidelines hit chronic sinusitis on the nose
In the U.S., sinusitis is more prevalent than arthritis and hypertension and, when chronic, can be as debilitating as diabetes and cardiovascular disease. Unfortunately, lack of a clear definition of chronic rhinosinusitis (CRS) has made it difficult for clinicians to provide effective care or develop new drug therapies. The Sinus and Allergy Health Partnership (SAHP) recently published guidelines that enumerate the multiple causes of and appropriate diagnosis criteria for CRS that may lead to improved therapies for the condition. The guidelines were published in a recent issue of Otolaryngology-Head and Neck Surgery.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
